Budzinska M, Zimna A, Kurpisz M
Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
J Physiol Pharmacol. 2021 Apr;72(2). doi: 10.26402/jpp.2021.2.01. Epub 2021 Aug 6.
Duchenne muscular dystrophy (DMD) is an X-linked lethal disorder caused by mutations in the dystrophin gene. Progression of this disease may lead to cardiomyopathy and respiratory failure, which are the main causes of death among DMD patients. Lack of dystrophin affects cellular myogenic function and related organelles. Dystrophin deficiency results in intracellular Ca dysregulation, mitochondrial dysfunction and induces elevated production of reactive oxygen species (ROS). Due to current findings, mitochondria may be also a potential target for DMD therapy. In this review we attempted to provide an insight into the role of mitochondria in perpetuation of DMD disease.
杜氏肌营养不良症(DMD)是一种由肌营养不良蛋白基因突变引起的X连锁致死性疾病。这种疾病的进展可能导致心肌病和呼吸衰竭,这是DMD患者死亡的主要原因。肌营养不良蛋白的缺乏会影响细胞的肌生成功能和相关细胞器。肌营养不良蛋白缺乏导致细胞内钙调节异常、线粒体功能障碍,并诱导活性氧(ROS)生成增加。基于目前的研究结果,线粒体可能也是DMD治疗的一个潜在靶点。在这篇综述中,我们试图深入探讨线粒体在DMD疾病持续发展中的作用。